FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Certificates

FDA

Document

No Title 0.21 MB
Registration Date 10 Nov 2014
Share

ABRAXANE®

(4.5)

Medicine Pharmaceuticals Product Number : 68817-134-50

Antineoplastic Agent

Drug Information

Generic
PACLITAXEL
NDC Code
68817-134-50
Drug Class
Mitotic inhibitors
Therapeutic Class
Antineoplastic
Dosage form
Powder
Route of Administration
Intravenous Injection
Therapeutic Area
1.Breast Cancer 2.Lung Cancer 3.Pancreatic Cancer

Nanomaterials

Manufacturer Asserted

Protein

Nanoparticle /Nanopowder

Benefit

Eliminates the use of toxic solvents that were essential for its microformulated counterpart